Clinical Trial Update: A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacodynamic activity of E2082 in adults with photosensitive epilepsy was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy

Drugs mentioned

• E2082

Snippet

Sponsor: Eisai Inc. | Conditions: Photosensitive Epilepsy | Phase 2 | Status: TERMINATED | Results posted: 2020-09-28